Polyendocrine metabolic ovarian syndrome is underdiagnosed and inconsistenly managed, according to Nice
Up to 4 million women with irregular periods should be investigated for polyendocrine metabolic ovarian syndrome, according to new NHS guidance.
PMOS, previously known as polycystic ovarian syndrome, is believed to affect up to 13% of reproductive age women, the World Health Organization estimates.
